Science Explorer Back to mapMap
Institution · Ospedale San Donato

Most cited papers from Ospedale San Donato

What are the most cited papers from Ospedale San Donato?

The most cited paper from Ospedale San Donato is "Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma" (Robert John Motzer et al., 2018), with 4,756 citations. Next come "Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma" (1,801) and "Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial" (1,756).

Showing 50 of 60 papers. Every paper with more than 144 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma Robert John Motzer et al. · New England Journal of Medicine Open access 21 Mar 2018 4,756
2 Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma Toni K. Choueiri et al. · New England Journal of Medicine Open access 3 Mar 2021 1,801
3 Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial Padmanee Sharma, Margitta M. Retz, Arlene Odelia Siefker-Radtke et al. · The Lancet Oncology 25 Jan 2017 1,756
4 Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma David F. McDermott et al. · Nature Medicine Open access 29 May 2018 1,280
5 Phase 3 trial of everolimus for metastatic renal cell carcinoma Robert John Motzer, Bernard J. Escudier, Stéphane Marie. Oudard et al. · Cancer 14 Jun 2010 1,148
6 Mapping the human genetic architecture of COVID-19 COVID-19 Host Genetics Initiative et al. · Nature Open access3,896 authors 8 Jul 2021 1,130
7 Phase III Trial of Bevacizumab Plus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma (AVOREN): Final Analysis of Overall Survival Bernard J. Escudier, Joaquim Bellmunt, Sylvie Négrier et al. · Journal of Clinical Oncology 6 Apr 2010 810
8 Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial Robert John Motzer et al. · The Lancet Oncology Open access 16 Aug 2019 797
9 Left Ventricular Remodeling After Primary Coronary Angioplasty Leonardo Bolognese, Aleksandar Nešković, Guido Parodi et al. · Circulation 28 Oct 2002 601
10 Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022 Andrea Antinori et al. · Eurosurveillance Open access 2 Jun 2022 580
11 A microfluidic 3D in vitro model for specificity of breast cancer metastasis to bone Simone Bersini, Jessie Sungyun Jeon, Gabriele Dubini et al. · Biomaterials Open access 2 Jan 2014 535
12 Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation Constantine L. Athanasuleas, Gerald D. Buckberg, Alfred W.H. Stanley et al. · Journal of the American College of Cardiology Open access Oct 2004 448
13 Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial Carlo Di Mario, Dariusz Dudek, Federico Piscione et al. · The Lancet Feb 2008 439
14 Impact of Microvascular Dysfunction on Left Ventricular Remodeling and Long-Term Clinical Outcome After Primary Coronary Angioplasty for Acute Myocardial Infarction Leonardo Bolognese, Nazario Carrabba, Guido Parodi et al. · Circulation 17 Feb 2004 429
15 ERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failure Simon JW Oczkowski et al. · European Respiratory Journal Open access 14 Oct 2021 407
16 Adjunctive Systemic Hyperbaric Oxygen Therapy in Treatment of Severe Prevalently Ischemic Diabetic Foot Ulcer: A randomized study Ezio Faglia, Favales Favales, Aldeghi Aldeghi et al. · Diabetes Care Dec 1996 395
17 Simple Risk Models to Predict Surgical Mortality in Acute Type A Aortic Dissection: The International Registry of Acute Aortic Dissection Score Vincenzo Rampoldi, Santi Trimarchi, Kim Allen Eagle et al. · The Annals of Thoracic Surgery 20 Dec 2006 389
18 Whole-genome sequencing reveals host factors underlying critical COVID-19 Athanasios Kousathanas et al. · Nature Open access2,399 authors 7 Mar 2022 356
19 Cardiac Involvement in Fabry Disease Maurizio Pieroni, James Moon, Eloisa Arbustini et al. · Journal of the American College of Cardiology Open access Feb 2021 331
20 Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer Karol Połom, Luigi Marano, Daniele Marrelli et al. · British journal of surgery Review Nov 2017 326
21 Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial Robert John Motzer, Thomas Powles, Mauricio Burotto et al. · The Lancet Oncology Open access 7 Jun 2022 323
22 Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss Johann Sebastian De Bono, Ugo De Giorgi, Daniel Nava Rodrigues et al. · Clinical Cancer Research 23 Jul 2018 317
23 Feasibility and clinical impact of out-of-ICU noninvasive respiratory support in patients with COVID-19-related pneumonia Cosimo Franco et al. · European Respiratory Journal Open access 3 Aug 2020 310
24 European Respiratory Society guidelines on long-term home non-invasive ventilation for management of COPD Begüm Ergan, Simon JW Oczkowski, Bram N. Rochwerg et al. · European Respiratory Journal Open access 29 Aug 2019 307
25 2020 WSES guidelines for the detection and management of bile duct injury during cholecystectomy Nicola de’Angelis et al. · World Journal of Emergency Surgery Open access 10 Jun 2021 284
26 Zotarolimus-Eluting Versus Bare-Metal Stents in Uncertain Drug-Eluting Stent Candidates Marco Valgimigli et al. · Journal of the American College of Cardiology Open access 23 Feb 2015 280
27 ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population Elisa Benetti et al. · European Journal of Human Genetics Open access138 authors 17 Jul 2020 270
28 Contemporary Role of Androgen Deprivation Therapy for Prostate Cancer Vincenzo Pagliarulo, Sergio Bracarda, Mario A. Eisenberger et al. · European Urology Open access 27 Aug 2011 263
29 Myocardial ischemia and coronary disease in heart failure Beniamino Pagliaro, F. Cannata, Giulio Giuseppe Stefanini et al. · Heart Failure Reviews 22 Jul 2019 249
30 Oropharyngeal Dysphagia after Stroke: Incidence, Diagnosis, and Clinical Predictors in Patients Admitted to a Neurorehabilitation Unit Paolo Falsetti, Caterina Acciai, Rosanna Palilla et al. · Journal of Stroke and Cerebrovascular Diseases 29 Aug 2009 247
31 Spectrum ofSCN1Amutations in severe myoclonic epilepsy of infancy Rima Nabbout et al. · Neurology 24 Jun 2003 245
32 Long-Term Followup of Bulbar End-to-End Anastomosis: A Retrospective Analysis of 153 Patients in a Single Center Experience Guido Barbagli, Michele De Angelis, Giuseppe Romano et al. · The Journal of Urology 10 Nov 2007 245
33 The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts Dominique Paul Germain, Perry Mark Elliott, Bruno Falissard et al. · Molecular Genetics and Metabolism Reports ReviewOpen access 10 Feb 2019 236
34 Safety issues with glucagon‐like peptide‐1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): D ata from randomized controlled trials Matteo Monami, Besmir Nreu, Alessia Scatena et al. · Diabetes Obesity and Metabolism 28 Feb 2017 236
35 An Expert Consensus Document on the Management of Cardiovascular Manifestations of Fabry Disease Aleš Linhart, Dominique Paul Germain, Iacopo Olivotto et al. · European Journal of Heart Failure Open access Jul 2020 228
36 Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial Francesco Boccardo, ALESSANDRA RUBAGOTTI, Pamela Guglielmini et al. · Annals of Oncology Open access Jun 2006 223
37 IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trial Brian I. Rini et al. · The Lancet Oncology 7 Oct 2016 221
38 Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study Chiara Fallerini et al. · eLife Open access148 authors 2 Mar 2021 218
39 European expert consensus statement on therapeutic goals in Fabry disease Christoph Wanner et al. · Molecular Genetics and Metabolism Open access 12 Jun 2018 218
40 Failed Hypospadias Repair Presenting in Adults Guido Barbagli, Michele De Angelis, Enzo Palminteri et al. · European Urology 4 Feb 2006 215
41 Andersen's syndrome: A distinct periodic paralysis Valeria Sansone, Robert C. Griggs, Giovanni Meola et al. · Annals of Neurology Open access Sep 1997 212
42 TauGene Mutation G389R Causes a Tauopathy with Abundant Pick Body-like Inclusions and Axonal Deposits Jill R. Murrell, Maria Grazia Spillantini, Paolo Zolo et al. · Journal of Neuropathology & Experimental Neurology Dec 1999 205
43 Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial Paolo Della Bella et al. · Circulation 3 Apr 2022 203
44 Surgical therapy for ischemic heart failure: Single-center experience with surgical anterior ventricular restoration Lorenzo Menicanti, Serenella Castelvecchio, Marco Ranucci et al. · Journal of Thoracic and Cardiovascular Surgery Open access 19 Jun 2007 194
45 Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma Martin Eric Gore et al. · British Journal of Cancer Open access Jun 2015 194
46 Diffusion-Weighted Imaging in Oncology: An Update Carmelo Messina, Rodolfo Bignone, Alberto Bruno et al. · Cancers Open access 8 Jun 2020 191
47 Drug-Eluting Balloon in Peripheral Intervention for the Superficial Femoral Artery Francesco Liïstro, Simone Grotti, Italo Porto et al. · JACC: Cardiovascular Interventions Open access 13 Nov 2013 187
48 Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review Finn Edler von Eyben, Giandomenico Roviello, Timo Kiljunen et al. · European Journal of Nuclear Medicine and Molecular Imaging ReviewOpen access 15 Dec 2017 185
49 A first update on mapping the human genetic architecture of COVID-19 COVID-19 Host Genetics Initiative et al. · Nature Open access1,102 authors 3 Aug 2022 179
50 A meta-analysis of GFR slope as a surrogate endpoint for kidney failure Lesley A. Inker et al. · Nature Medicine ReviewOpen access 17 Jun 2023 174

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.